Tech & Pharma
The University of Melbourne and Procypra Therapeutics have agreed to develop therapy to treat Parkinson’s disease.
A six million dollar Australia-India partnership project will focus on improving processes involved in the production of dimethyl ether (DME), a clean-burning synthetic fuel.
Research institutes in Singapore and Korea will team up to promote joint research and collaboration in the field of sustainable chemicals.
Takeda has announced the results of a Phase 1/2 study of its norovirus vaccine candidate which was found to be well tolerated.
Hutchison MediPharma has entered into a collaboration with Eli Lilly to develop fruquintinib, a targeted oncology therapy against solid tumors.
Apollo Hospitals and Medtronic have announced a collaboration to bring an affordable and portable hemodialysis system to India.
ASLAN Pharmaceuticals has raised US$22 million after hosting a second round of financing with Cenova Ventures.
Otsuka Pharma has successfully completed its acquisition of Astex Pharmaceuticals, Inc. for US$8.50 per share.
Micell Technologies and Hefei Life Science will develop, market and distribute the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System in China.
PAREXEL has launched a service called China Trials Solution to provide clients with local market knowledge and resources.